Separate names with a comma.
PUBMED - Single Treatment With MM120 (Lysergide) in Generalized Anxiety Disorder: A Randomized Clinical Trial -...
$ATAI atai Life Sciences: The Leader in Psychedelic Therapeutics -...
Move Over Xanax? New Research on LSD Offers Hope for Anxiety...
+24% today
atai Life Sciences, Beckley Psytech get FDA breakthrough therapy status for BPL-003...
atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in...
Intranasal Psychedelic Gets Breakthrough Tx Status for Treatment-Resistant Depression...
ExtracTech Information: https://www.metaflotech.com/products/biopolymers/extractech/...
Super Copper and MetaFLO Announce Joint Venture to Develop Biopolymer Solutions for Copper Mining...
Metals veteran sees $12,000 copper price this year https://www.mining.com/web/metals-veteran-sees-12000-copper-price-this-year/
+$4.63 (337.96%) Year to Date
Up 12.41% Today :)
According to @JNJNews Q3’25 earnings tables, their “psychedelic-like” blockbuster SPRAVATO is accelerating fast - now closing in on a $2B annual...
MindMed Announces New Employee Inducement Grant...
BREAKING - Freeport to break away from copper benchmark it set for decades (How it can affect $CUPPF and other junior miners)...
$MNMD Mind Medicine Nears Pivotal Year: Strong Fundamentals Make It A Buy...
ATAI Life Sciences files update on Beckley Psytech acquisition plans...
